These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16686067)

  • 41. Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary.
    Sarvary E; Nagy P; Benjamin A; Szoke M; Remport A; Jansen J; Nemes B; Kobori L; Fehervari I; Sulyok B; Perner F; Varga M; Fazakas J; Lakatos M; Szabo M; Toth A; Járay J
    Transplant Proc; 2005 Mar; 37(2):969-72. PubMed ID: 15848594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Parkinson N; Krishnamoorthy M; Freedman MH; Malkin D
    Cancer Gene Ther; 2006 Apr; 13(4):415-9. PubMed ID: 16211088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of recurrent malignant gliomas by surgery combined with recombinant adenovirus-p53 injection].
    Zhu JX; Li ZM; Geng FY; Fu Q; Guo CJ; Xiao YL; Zhang ZT; Li G
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):709-12. PubMed ID: 21122390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical importance of serum anti-p53 antibodies as tumor markers].
    Sakai H; Okamoto E
    Rinsho Byori; 2002 Oct; 50(10):970-5. PubMed ID: 12451677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa.
    Emmerich P; Thome-Bolduan C; Drosten C; Gunther S; Ban E; Sawinsky I; Schmitz H
    J Clin Virol; 2006 Dec; 37(4):277-81. PubMed ID: 16996789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation of human antibodies against the central DNA binding domain of p53 from an individual with colorectal cancer using antibody phage display.
    Coomber DW; Ward RL
    Clin Cancer Res; 2001 Sep; 7(9):2802-8. PubMed ID: 11555596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
    Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
    Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.
    Creaney J; McLaren BM; Stevenson S; Musk AW; de Klerk N; Robinson BW; Lake RA
    Br J Cancer; 2001 Jan; 84(1):52-6. PubMed ID: 11139313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TP53 gene in blood plasma DNA of tumor patients.
    Schlechte HH; Stelzer C; Weickmann S; Fleischhacker M; Schulze G
    Ann N Y Acad Sci; 2004 Jun; 1022():61-9. PubMed ID: 15251941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
    Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic significance in serum presence of anti-p53 antibody in patients with colorectal carcinoma.
    Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
    Hepatogastroenterology; 2007; 54(77):1422-5. PubMed ID: 17708268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods].
    Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O
    Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections.
    Vázquez S; Cabezas S; Pérez AB; Pupo M; Ruiz D; Calzada N; Bernardo L; Castro O; González D; Serrano T; Sanchez A; Guzmán MG
    Int J Infect Dis; 2007 May; 11(3):256-62. PubMed ID: 16914345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
    Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
    Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
    Lai TJ; Tsai YY; Cheng YW; Chiang CC; Lee H; Chou MC; Chang JH
    Mol Vis; 2006 Dec; 12():1687-91. PubMed ID: 17213797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
    Shimada H; Ochiai T; Nomura F;
    Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.